| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/ATVBAHA.115.305655 |
| P698 | PubMed publication ID | 26044583 |
| P50 | author | Sven Nylander | Q108491101 |
| P2093 | author name string | Yochai Birnbaum | |
| Yumei Ye | |||
| Gilad D Birnbaum | |||
| Jose R Perez-Polo | |||
| Manjyot K Nanhwan | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | reperfusion injury | Q1413991 |
| P304 | page(s) | 1805-1814 | |
| P577 | publication date | 2015-06-04 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction | |
| P478 | volume | 35 |
| Q57788702 | Accurate measurement of endogenous adenosine in human blood |
| Q64239467 | Beyond Reperfusion: Acute Ventricular Unloading and Cardioprotection During Myocardial Infarction |
| Q26799623 | Blood cells: an historical account of the roles of purinergic signalling |
| Q89542900 | Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function |
| Q39388843 | Cell Death in the Vessel Wall: The Good, the Bad, the Ugly. |
| Q52353228 | Do platelets promote cardiac recovery post myocardial infarction: Roles beyond occlusive ischemic damage. |
| Q60950476 | Effect of Potent P2Y Inhibitors on Ventricular Arrhythmias and Cardiac Dysfunction in Coronary Artery Disease: A Systematic Review and Meta-Analysis |
| Q58077038 | Effect of Ticagrelor on Coronary Blood Flow and Prognosis in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in Real World |
| Q38694069 | Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines |
| Q42364551 | Effects of Ticagrelor on Myocardial Infarct Size. |
| Q41865115 | Effects of ticagrelor in a mouse model of ischemic stroke. |
| Q98226403 | Efficacy of a Novel Mitochondrial-Derived Peptide in a Porcine Model of Myocardial Ischemia/Reperfusion Injury |
| Q37076189 | Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study |
| Q90700337 | Innate immunity as a target for acute cardioprotection |
| Q38724161 | MicroRNA-142-3p inhibits hypoxia/reoxygenation‑induced apoptosis and fibrosis of cardiomyocytes by targeting high mobility group box 1. |
| Q93024156 | Platelet inhibition to target reperfusion injury trial: Rationale and study design |
| Q93345064 | Platelets Protect Cardiomyocytes from Ischaemic Damage |
| Q64274965 | Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target |
| Q91909003 | Rationale and Design of the High Platelet Inhibition with Ticagrelor to Improve Left Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction (HEALING-AMI) Trial |
| Q58197547 | Research update for articles published in EJCI in 2014 |
| Q50598217 | The Effect of Clopidogrel on the Response to Ischemia Reperfusion. |
| Q87809937 | The Highly Selective Caspase-1 Inhibitor VX-765 Provides Additive Protection Against Myocardial Infarction in Rat Hearts When Combined With a Platelet Inhibitor |
| Q48649274 | The impact of irreproducibility and competing protection from P2Y12 antagonists on the discovery of cardioprotective interventions |
| Q89686323 | Ticagrelor Enhances Release of Anti-Hypoxic Cardiac Progenitor Cell-Derived Exosomes Through Increasing Cell Proliferation In Vitro |
| Q48235186 | Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine |
| Q48141318 | Ticagrelor attenuates myocardial ischemia-reperfusion injury possibly through downregulating galectin-3 expression in the infarct area of rats |
| Q38869502 | Ticagrelor for the treatment of atherosclerotic disease: insights from the PARTHENON clinical development program |
| Q48265369 | Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer. |
| Q38675528 | Ticagrelor mitigates ischaemia-reperfusion induced vascular endothelial dysfunction in healthy young males - a randomized, single-blinded study. |
| Q90151481 | Ticagrelor versus clopidogrel in the management of acute myocardial infarction |
| Q48219913 | Unraveling the Interaction of Aspirin, Ticagrelor, and Rosuvastatin on the Progression of Atherosclerosis and Inflammation in Diabetic Mice. |
| Q64272828 | Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome |
| Q93057074 | Will Ticagrelor Help Post-Myocardial Infarction 'Healing'? |
| Q51363751 | miR-192-5p mediates hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes via targeting of FABP3. |
Search more.